Filing Details
- Accession Number:
- 0001209191-18-042312
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-07-11 16:10:54
- Reporting Period:
- 2018-07-09
- Accepted Time:
- 2018-07-11 16:10:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1350360 | Jason Cole | C/O Bluebird Bio, Inc. 60 Binney Street Cambridge MA 02142 | Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-07-09 | 600 | $168.47 | 21,698 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-07-09 | 2,290 | $169.64 | 19,408 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-07-09 | 970 | $170.68 | 18,438 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-07-09 | 940 | $171.60 | 17,498 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-07-09 | 326 | $172.66 | 17,172 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2017.
- The range in prices for the transaction reported on this line was $168.15 to $169.00. The average weighted price was $168.4667. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $169.25 to $170.20. The average weighted price was $169.6438. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $170.25 to $171.15. The average weighted price was $170.6762. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $171.25 to $172.15. The average weighted price was $171.6022. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $172.45 to $172.85. The average weighted price was $172.6647. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.